Alison Tyson-Capper

1.3k total citations
40 papers, 948 citations indexed

About

Alison Tyson-Capper is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Alison Tyson-Capper has authored 40 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Oncology. Recurrent topics in Alison Tyson-Capper's work include RNA Research and Splicing (12 papers), Orthopaedic implants and arthroplasty (8 papers) and RNA and protein synthesis mechanisms (8 papers). Alison Tyson-Capper is often cited by papers focused on RNA Research and Splicing (12 papers), Orthopaedic implants and arthroplasty (8 papers) and RNA and protein synthesis mechanisms (8 papers). Alison Tyson-Capper collaborates with scholars based in United Kingdom, United States and Slovenia. Alison Tyson-Capper's co-authors include Hannah Gautrey, Kelly Harper, David Browell, Thomas W. J. Lennard, Claire Jackson, John A. Kirby, Stephen C. Robson, G. Nicholas Europe‐Finner, David J. Elliott and Jarrod Bailey and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Alison Tyson-Capper

38 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Tyson-Capper United Kingdom 19 577 182 171 114 89 40 948
Jin‐Sook Jeong South Korea 20 583 1.0× 202 1.1× 212 1.2× 51 0.4× 107 1.2× 57 1.0k
Chun‐Jung Ko Taiwan 18 356 0.6× 156 0.9× 152 0.9× 216 1.9× 63 0.7× 28 818
Beibei Ni China 15 480 0.8× 186 1.0× 133 0.8× 104 0.9× 71 0.8× 33 740
Detlef Kozian Germany 13 729 1.3× 131 0.7× 141 0.8× 108 0.9× 92 1.0× 21 1.0k
Jolanta Niewiarowska Poland 18 493 0.9× 228 1.3× 208 1.2× 123 1.1× 70 0.8× 39 947
Lin Ye China 19 737 1.3× 331 1.8× 184 1.1× 96 0.8× 84 0.9× 45 1.1k
Lihui Li China 14 589 1.0× 131 0.7× 253 1.5× 118 1.0× 62 0.7× 41 927
Xi Xia China 22 517 0.9× 234 1.3× 129 0.8× 152 1.3× 120 1.3× 53 1.1k

Countries citing papers authored by Alison Tyson-Capper

Since Specialization
Citations

This map shows the geographic impact of Alison Tyson-Capper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Tyson-Capper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Tyson-Capper more than expected).

Fields of papers citing papers by Alison Tyson-Capper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Tyson-Capper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Tyson-Capper. The network helps show where Alison Tyson-Capper may publish in the future.

Co-authorship network of co-authors of Alison Tyson-Capper

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Tyson-Capper. A scholar is included among the top collaborators of Alison Tyson-Capper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Tyson-Capper. Alison Tyson-Capper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deehan, David J., et al.. (2025). Poly-ether-ether-ketone wear particles induce a pro-inflammatory phenotype in a human monocytic cell line. Frontiers in Bioengineering and Biotechnology. 13. 1507248–1507248.
2.
Deehan, David J., et al.. (2021). Inflammatory responses to metal oxide ceramic nanopowders. Scientific Reports. 11(1). 10531–10531. 11 indexed citations
3.
Gautrey, Hannah, et al.. (2021). HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer. Journal of Cancer Research and Clinical Oncology. 147(10). 2893–2912. 5 indexed citations
5.
Stanton, Anna, Catherine Mowbray, Karen Brown, et al.. (2020). Topical Estrogen Treatment Augments the Vaginal Response to Escherichia coli Flagellin. Scientific Reports. 10(1). 8473–8473. 9 indexed citations
6.
Ali, Ased, Catherine Mowbray, Anna Stanton, et al.. (2017). Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection. Scientific Reports. 7(1). 11039–11039. 15 indexed citations
7.
Deehan, David J., et al.. (2016). Cobalt ions recruit inflammatory cells in vitro through human Toll-like receptor 4. Biochemistry and Biophysics Reports. 7. 374–378. 19 indexed citations
8.
Danilenko, Marina, Caroline Dalgliesh, Vittoria Pagliarini, et al.. (2016). Binding site density enables paralog-specific activity of SLM2 and Sam68 proteins in Neurexin2 AS4 splicing control. Nucleic Acids Research. 45(7). gkw1277–gkw1277. 13 indexed citations
9.
Gautrey, Hannah, et al.. (2015). SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells. RNA Biology. 12(10). 1139–1151. 67 indexed citations
10.
Gautrey, Hannah, et al.. (2015). Deregulation of splicing factors and breast cancer development. Journal of Molecular Cell Biology. 7(5). 388–401. 39 indexed citations
11.
Gautrey, Hannah, et al.. (2014). The HER2 Signaling Network in Breast Cancer—Like a Spider in its Web. Journal of Mammary Gland Biology and Neoplasia. 19(3-4). 253–270. 65 indexed citations
12.
Eyre, Rachel, I. J. Harvey, Katherine Stemke‐Hale, et al.. (2014). Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population. Tumor Biology. 35(10). 9879–9892. 43 indexed citations
13.
Best, Andrew, Katherine James, Caroline Dalgliesh, et al.. (2014). Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons. Nature Communications. 5(1). 4760–4760. 43 indexed citations
14.
Lennard, Thomas W. J., et al.. (2012). Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative. Tumor Biology. 33(6). 2329–2340. 5 indexed citations
15.
Tyson-Capper, Alison, et al.. (2009). Interplay between polypyrimidine tract binding protein-associated splicing factor and human myometrial progesterone receptors. Journal of Molecular Endocrinology. 43(1). 29–41. 4 indexed citations
16.
Lennard, Thomas W. J., et al.. (2008). Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Research. 10(3). 207–207. 43 indexed citations
17.
18.
Tyson-Capper, Alison, et al.. (2006). Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy. Molecular Human Reproduction. 12(11). 695–701. 8 indexed citations
19.
Phillips, Robert, Alison Tyson-Capper, Jarrod Bailey, Stephen C. Robson, & G. Nicholas Europe‐Finner. (2005). Regulation of Expression of the Chorionic Gonadotropin/Luteinizing Hormone Receptor Gene in the Human Myometrium: Involvement of Specificity Protein-1 (Sp1), Sp3, Sp4, Sp-Like Proteins, and Histone Deacetylases. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3479–3490. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026